BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/12/2022 4:01:56 AM | Browse: 297 | Download: 996
 |
Received |
|
2021-08-08 16:16 |
|
Peer-Review Started |
|
2021-08-08 16:19 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-10-11 08:31 |
|
Revised |
|
2021-10-19 16:33 |
|
Second Decision |
|
2021-12-06 03:26 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2021-12-08 05:06 |
|
Articles in Press |
|
2021-12-08 05:06 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-11-30 01:06 |
|
Typeset the Manuscript |
|
2021-12-29 07:22 |
|
Publish the Manuscript Online |
|
2022-01-12 04:01 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Scientometrics |
| Article Title |
Biologic therapy for Crohn’s disease over the last 3 decades
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Ji-Liang Shen, Zheng Zhou, Jia-Sheng Cao, Bin Zhang, Jia-Hao Hu, Jia-Ying Li, Xiao-Ming Liu, Sarun Juengpanich, Ming-Song Li and Xu Feng |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China (General Program) |
81800540 |
| Key Research and Development Project of Zhejiang Province |
2018C03083 |
|
| Corresponding Author |
Xu Feng, MD, PhD, Surgeon, Department of General Surgery, Sir Run-Run Shaw Hospital, Zhejiang University School of Medicine, No.3 East Qingchun Road, Hangzhou 310016, Zhejiang Province, China. phoneshe@zju.edu.cn |
| Key Words |
Biologic therapy; Crohn’s disease; Bibliometric analysis; Most influential; Insight |
| Core Tip |
We conducted a bibliometric analysis from the top 100 highest-cited original articles to determine knowledge gaps and identify areas of interest of biologic therapy for Crohn’s disease (CD). The 2000s yielded the most influential original articles and saw the most dramatic growth. The United States and Europe contributed the most publications, and the cooperation relationships between them were most frequent. Gastroenterology published the most articles on biologic therapy for CD. Anti-tumor necrosis factor (TNF) biologics and monoclonal antibodies were the most studied topics. These data would provide useful research insights into biologic therapy for CD for clinicians and researchers. |
| Publish Date |
2022-01-12 04:01 |
| Citation |
Shen JL, Zhou Z, Cao JS, Zhang B, Hu JH, Li JY, Liu XM, Juengpanich S, Li MS, Feng X. Biologic therapy for Crohn’s disease over the last 3 decades. World J Clin Cases 2022; 10(2): 594-606 |
| URL |
https://www.wjgnet.com/2307-8960/full/v10/i2/594.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v10.i2.594 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
